Regulations.gov document
Determination That the OXYCONTIN (oxycodone hydrochloride) Drug Products Covered by New…
Notice · FDA-2001-P-0238 · posted Apr 18, 2013
Key facts
| Document ID | FDA-2001-P-0238-0002 |
|---|---|
| Title | Determination That the OXYCONTIN (oxycodone hydrochloride) Drug Products Covered by New Drug Application 20-553 Were Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2001-P-0238 |
| Posted | Apr 18, 2013 |
| Federal Register citation | 78 FR 23273 |
| FR document number | 2013-09092 |
| Comment period opens | Apr 18, 2013 |
| Effective date | Apr 18, 2013 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: